These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 14764125)

  • 21. Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up.
    Minardi D; Lucarini G; Filosa A; Milanese G; Zizzi A; Di Primio R; Montironi R; Muzzonigro G
    Int J Immunopathol Pharmacol; 2008; 21(2):447-55. PubMed ID: 18547492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type 1 plasminogen activator inhibitor (PAI-1) in clear cell renal cell carcinoma (CCRCC) and its impact on angiogenesis, progression and patient survival after radical nephrectomy.
    Zubac DP; Wentzel-Larsen T; Seidal T; Bostad L
    BMC Urol; 2010 Dec; 10():20. PubMed ID: 21129210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low differentiated microvascular density and low expression of platelet-derived growth factor-BB (PDGF-BB) predict distant metastasis and poor prognosis in clear cell renal cell carcinoma.
    Qi L; Du J; Zhang Z; Diao L; Chen X; Yao X
    BJU Int; 2013 Aug; 112(4):E415-23. PubMed ID: 23879920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphangiogenesis and angiogenesis in conventional renal cell carcinoma: association with vascular endothelial growth factors A to D immunohistochemistry.
    Iwata T; Miyata Y; Kanda S; Nishikido M; Hayashi T; Sakai H; Kanetake H
    Urology; 2008 Apr; 71(4):749-54. PubMed ID: 18295862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.
    Miyata Y; Iwata T; Ohba K; Kanda S; Nishikido M; Kanetake H
    Clin Cancer Res; 2006 Dec; 12(23):6998-7003. PubMed ID: 17145820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor angiogenesis and metastasis: correlation in invasive renal cell carcinoma.
    Ou YC; Chen JT; Yang CR; Horng YY; Kao YL; Cheng CL
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Aug; 61(8):441-7. PubMed ID: 9745159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclooxygenase-2 and p53 expression as prognostic indicators in conventional renal cell carcinoma.
    Cho DS; Joo HJ; Oh DK; Kang JH; Kim YS; Lee KB; Kim SJ
    Yonsei Med J; 2005 Feb; 46(1):133-40. PubMed ID: 15744816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correlation of multislice spiral CT findings with vascular endothelial growth factor expressions and microvessel density in renal cell carcinoma].
    Xia J; Luo P; Wang H; Lei Y; Liu PN; Xu HJ; Chen ZG
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):629-31. PubMed ID: 16762869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter.
    Inoue K; Kamada M; Slaton JW; Fukata S; Yoshikawa C; Tamboli P; Dinney CP; Shuin T
    Clin Cancer Res; 2002 Jun; 8(6):1863-70. PubMed ID: 12060629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of vascular endothelial growth factor and hypoxia-inducible factor-1α expression with pathological renal artery changes in patients with renal cell carcinoma.
    Demirović A; Tomas D; Tomić K; Spajić B; Ibukić A; Cupić H; Krušlin B
    Scand J Urol; 2014 Feb; 48(1):34-40. PubMed ID: 24256617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of vascular endothelial growth factor expression in clear cell renal cell carcinoma.
    Djordjevic G; Mozetic V; Mozetic DV; Licul V; Ilijas KM; Mustac E; Oguic R; Fuckar Z; Jonjic N
    Pathol Res Pract; 2007; 203(2):99-106. PubMed ID: 17270362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma.
    Sabo E; Boltenko A; Sova Y; Stein A; Kleinhaus S; Resnick MB
    Clin Cancer Res; 2001 Mar; 7(3):533-7. PubMed ID: 11297244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival.
    Zubac DP; Bostad L; Kihl B; Seidal T; Wentzel-Larsen T; Haukaas SA
    J Urol; 2009 Nov; 182(5):2144-9. PubMed ID: 19758660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma.
    Gelb AB; Sudilovsky D; Wu CD; Weiss LM; Medeiros LJ
    Cancer; 1997 Nov; 80(9):1768-75. PubMed ID: 9351546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. mTOR and mTOR phosphorylation status in primary and metastatic renal cell carcinoma tissue: differential expression and clinical relevance.
    Rausch S; Schollenberger D; Hennenlotter J; Stühler V; Kruck S; Stenzl A; Bedke J
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):153-163. PubMed ID: 30368665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer.
    Mertz KD; Demichelis F; Kim R; Schraml P; Storz M; Diener PA; Moch H; Rubin MA
    Hum Pathol; 2007 Oct; 38(10):1454-62. PubMed ID: 17889675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High expression of Twist is associated with tumor aggressiveness and poor prognosis in patients with renal cell carcinoma.
    Ohba K; Miyata Y; Matsuo T; Asai A; Mitsunari K; Shida Y; Kanda S; Sakai H
    Int J Clin Exp Pathol; 2014; 7(6):3158-65. PubMed ID: 25031735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiogenesis in renal cell carcinoma: the role of tumor-associated macrophages.
    Toge H; Inagaki T; Kojimoto Y; Shinka T; Hara I
    Int J Urol; 2009 Oct; 16(10):801-7. PubMed ID: 19811548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced expression of vasohibin-1 is associated with clinicopathological features in renal cell carcinoma.
    Zhao G; Yang Y; Tang Y; Han R; Sun Y
    Med Oncol; 2012 Dec; 29(5):3325-34. PubMed ID: 22865127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Correlation of microvascular density and clinicopathological factors in different subtypes of renal cell carcinoma].
    Zhang YH; Yang Q; Cui W; Liu YX; Liu SX; Yao X
    Zhonghua Zhong Liu Za Zhi; 2010 Feb; 32(2):117-22. PubMed ID: 20403242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.